Symbol="VIRX"
AssetType="Common Stock"
Name="Viracta Therapeutics Inc"
Description="Viracta Therapeutics, Inc., a precision oncology company, is dedicated to developing drugs for the treatment of virus-associated malignancies. The company is headquartered in Cardiff-by-the-Sea, California."
CIK="1061027"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="395 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="59537000"
EBITDA="-52086000"
PERatio="None"
PEGRatio="None"
BookValue="1.189"
DividendPerShare="0"
DividendYield="0"
EPS="-1.43"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.355"
ReturnOnEquityTTM="-0.744"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="10"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.182"
EVToRevenue="-"
EVToEBITDA="-0.148"
Beta="-0.218"
num_52WeekHigh="5.75"
num_52WeekLow="0.88"
num_50DayMovingAverage="1.471"
num_200DayMovingAverage="2.033"
SharesOutstanding="38410900"
DividendDate="2020-09-03"
ExDividendDate="None"
symbol="VIRX"
open="1.58"
high="1.64"
low="1.51"
price="1.55"
volume="158146.00"
latest_trading_day="2023-07-20"
previous_close="1.58"
change="-0.03"
change_percent="-1.8987%"
aroon_positive_momentum_days="65"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="185479"
Change_recent_avg="-0.02"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.48"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="494"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0111.jpeg"
image_negative_thumbnail_id_2="502"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0103.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="619"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_positive_thumbnail_id_2="600"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0108.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
